leisure time -WSS

leisure time

author：knowledge 2025-09-29 23:12:36 - browse：5

Adam's take main illustration — Molly Ferguson/STAT

MoonLake Immunotherapeutics, a Swiss biotech, was buried Monday under an avalanche of its own data spin.

It’s been awhile since I encountered a management team that speaks so arrogantly about the supposed supremacy of its own drug, but then fails to back up the talk with real data. MoonLake claimed its experimental antibody called sonelokimab delivered “landmark” results in a mid-stage study of psoriatic arthritis.

Landmark? That’s a strange way of describing the results of a clinical trial that showed sonelokimab topping a placebo — an easy hurdle — but failing to separate from an active treatment comparator, the generic drug adalimumab (known better as Humira).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： UnitedHealth financials solid despite Change Healthcare cyberattack

focus

leisure time

WSS

H5N1 bird flu virus started spreading in cows in Texas in December

FDA clears AI tool for detecting skin cancer

Health care needs a new profession: neuroimaging counseling

H5N1 bird flu virus started spreading in cows in Texas in December

Q&A: Jennifer Adair on making gene therapy available globally

Parkinson’s finding may lead to tests and, someday, treatments

knowledge

leisure time

Wikipedia

Moonlake's readout produced a cash windfall. Risks remain

UnitedHealth financials solid despite Change Healthcare cyberattack

Supreme Court strikes down use of affirmative action

Cholera vaccine supply gets boost as demand surges globally

Medical records are filled with copy

Humana cuts profit projections as Medicare Advantage costs soar

The cancer drug shortage isn’t new — and neither are the solutions

Humana cuts profit projections as Medicare Advantage costs soar

Heart attack and stroke risk calculators need revising

Cholera vaccine supply gets boost as demand surges globally

focus

The surgeon had a dilemma only a Nazi medical text could resolve

Cancer researcher Catriona Jamieson is sending tumors into space

Melinda French Gates resigns from Gates Foundation

Medical bills so high, Medicare adding extra digits to claim forms

AI generated plenty of interest at JPM but not a lot of trust

Readout Newsletter: Merck, J&J, and long Covid

focus

leisure time

explore

knowledge